Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1651-1657

  Saner, Fuat H ^a   Treckmann, Juergen W ^a   Geis, Alexander ^a   Lösch, Christian ^a   Witzke, Oliver ^a   Canbay, Ali ^a   Herget Rosenthal, Stephan ^a,b   Kribben, Andreas ^a   Paul, Andreas ^a   Feldkamp, Thorsten ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Rotes Kreuz Krankenhaus   (Germany)

Author keywords

citrate anticoagulation; intensive care; liver transplantation; renal replacement therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CITRIC ACID; CREATININE; GLUCONATE CALCIUM; HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOCALCEMIA; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; KIDNEY GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PH MEASUREMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REFERENCE VALUE; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION;

ACUTE KIDNEY INJURY; ANTICOAGULANTS; CITRATES; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES;

EID: 84859346478     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr510     Document Type: Article

References (39)

1. Gonwa TA, Mai ML, Melton LB et al. Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation 2001; 71: 1424-1428 (Pubitemid 32507116)
2. Sauer KM, Saner FH, Geis A et al. The impact of acute kidney injury on mortality and morbidity in patients after liver transplantation. Transpl Int 2010; 23: 20-20
3. Remuzzi G. Bleeding in renal failure. Lancet 1988; 1: 1205-1208
4. Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial 2009; 22: 141-145
5. Caruana RJ, Smith MC, Clyne D et al. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis. Blood Purif 1991; 9: 296-304
6. Swartz RD, Flamenbaum W, Dubrow A et al. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol 1988; 28: 818-825 (Pubitemid 19012988)
7. Saner F, Kavuk I, Lang H et al. Postoperative ICU management in liver transplant patients. Eur J Med Res 2003; 8: 511-516
8. Monchi M, Berghmans D, Ledoux D et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30: 260-265 (Pubitemid 38253417)
9. Tolwani AJ, Davenport A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. Neprol Dial Transplant plus 2009; 2: 439-447
10. Stavropoulou MS, Herget-Rosenthal S, Weber A et al. Serum citrate levels in patients receiving citrate during renal replacement therapy on the ICU. Nieren und Hochdruckkrankheiten 2008; 37: 47211.
11. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-261 (Pubitemid 13174358)
12. von Brecht JH, Flanigan MJ, Freeman RM et al. Regional anticoagulation: hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis 1986; 8: 196-201 (Pubitemid 17217095)
13. Diaz J, Acosta F, Parrilla P et al. Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem 1995; 28: 315-317
14. Meier-Kriesche HU, Gitomer J, Finkel K et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29: 748-752 (Pubitemid 32299711)
15. Faybik P, Hetz H, Mitterer G et al. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 2011; 39: 273-279
16. Mitchell A, Daul AE, BeiderlindenMet al. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol 2003; 59: 106-114 (Pubitemid 36221745)
17. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-1997 (Pubitemid 29197989)
18. Tobe SW, Aujla P, Walele AA et al. A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 2003; 18: 121-129 (Pubitemid 36759164)
19. Saner FH, Olde Damink SW, Pavlakovic G et al. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008; 85: 1564-1568
20. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
21. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcomemeasures, animalmodels, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)Group. CritCare 2004; 8: R204-R212
22. Bone RC. Abnormal cellular metabolism in sepsis. A new interpretation. JAMA 1992; 267: 1518-1519
23. Mehta RL, McDonald BR, Aguilar MM et al. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-981 (Pubitemid 20362872)
24. Morgera S, Scholle C, Voss G et al. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004; 97: c131-c136 (Pubitemid 39179245)
25. Llach F, Weidmann P, Reinhart R et al. Effect of acute and longstanding hypocalcaemia on blood pressure and plasma renin activity in man. J Clin Endocrinol Metab 1974; 38: 841-847
26. Zaloga GP. Hypocalcaemia in critically ill patients. Crit Care Med 1992; 20: 251-262
27. Forsythe RM, Wessel CB, Billiar TR et al. Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev 2008; (4): CD006163
28. Morgera S, Haase M, Ruckert M et al. Regional citrate anticoagulation in continuous hemodialysis-acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005; 101: c211-c219
29. Mehta RL, McDonald BR, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 1991; 93: 210-214
30. Oudemans-van Straaten HM, Bosman RJ, Koopmans M et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37: 545-552
31. Hetzel GR, Schmitz M, Wissing H et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232-239
32. Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11: 218
33. Baldwin J, Bellomo R. Flow reductions associated with CVVH: A comparison of frequency, severity and duration between access catheter sites. Blood Purif 1999; 17: 9A
34. Mariano F, Tedeschi L, Morselli M et al. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 2010; 36: 1735-1743
35. Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 1997; 30: S20-S27 (Pubitemid 27465336)
36. Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost 2006; 4: 717-720
37. Agarwal B, Shaw S, Hari MS et al. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? J Hepatol 2009; 51: 504-509
38. Kutsogiannis DJ, Gibney RT, Stollery D et al. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67: 2361-2367 (Pubitemid 41623398)
39. Swartz RD, Port FK. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 1979; 16: 513-518 (Pubitemid 10195862)